Moberg Pharma AB (publ) (MOB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.002x

Based on the latest financial reports, Moberg Pharma AB (publ) (MOB) has a cash flow conversion efficiency ratio of 0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.52 Million ≈ $163.36K USD) by net assets (Skr665.22 Million ≈ $71.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Moberg Pharma AB (publ) balance sheet independence to measure how much of total assets are equity-financed.

Moberg Pharma AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Moberg Pharma AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Moberg Pharma AB (publ)'s earnings quality to evaluate the quality of earnings relative to operating cash generation.

Moberg Pharma AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Moberg Pharma AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ckd Bio KO:063160	0.006x
Daily Polymer TWO:4716	0.039x
Keum Kang Steel Co. Ltd KQ:053260	-0.014x
INITECH Co. Ltd KQ:053350	-0.003x
MACH7 Technologies Ltd AU:M7T	0.073x
Hexza Corporation Bhd KLSE:3298	-0.017x
Cenit Co. Ltd KQ:037760	-0.013x
Amplia Therapeutics Ltd AU:ATX	-0.028x

Annual Cash Flow Conversion Efficiency for Moberg Pharma AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of Moberg Pharma AB (publ) from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see MOB company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr665.22 Million ≈ $71.59 Million	Skr-17.49 Million ≈ $-1.88 Million	-0.026x	-9.63%
2024-12-31	Skr686.82 Million ≈ $73.91 Million	Skr-16.47 Million ≈ $-1.77 Million	-0.024x	+55.89%
2023-12-31	Skr610.73 Million ≈ $65.72 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.054x	-72.25%
2022-12-31	Skr533.58 Million ≈ $57.42 Million	Skr-16.84 Million ≈ $-1.81 Million	-0.032x	+10.43%
2021-12-31	Skr434.05 Million ≈ $46.71 Million	Skr-15.30 Million ≈ $-1.65 Million	-0.035x	+53.42%
2020-12-31	Skr395.58 Million ≈ $42.57 Million	Skr-29.93 Million ≈ $-3.22 Million	-0.076x	-302.29%
2019-12-31	Skr105.68 Million ≈ $11.37 Million	Skr3.95 Million ≈ $425.30K	0.037x	-69.94%
2018-12-31	Skr594.02 Million ≈ $63.93 Million	Skr73.89 Million ≈ $7.95 Million	0.124x	+27.68%
2017-12-31	Skr552.41 Million ≈ $59.45 Million	Skr53.82 Million ≈ $5.79 Million	0.097x	+404.98%
2016-12-31	Skr561.62 Million ≈ $60.44 Million	Skr-17.94 Million ≈ $-1.93 Million	-0.032x	-136.69%
2015-12-31	Skr352.82 Million ≈ $37.97 Million	Skr30.72 Million ≈ $3.31 Million	0.087x	+63.63%
2014-12-31	Skr303.75 Million ≈ $32.69 Million	Skr16.16 Million ≈ $1.74 Million	0.053x	+440.35%
2013-12-31	Skr201.49 Million ≈ $21.68 Million	Skr-3.15 Million ≈ $-338.99K	-0.016x	-129.40%
2012-12-31	Skr178.23 Million ≈ $19.18 Million	Skr9.48 Million ≈ $1.02 Million	0.053x	+145.26%
2011-12-31	Skr76.79 Million ≈ $8.26 Million	Skr-9.02 Million ≈ $-970.70K	-0.117x	+99.73%
2010-12-31	Skr687.70K ≈ $74.01K	Skr-30.41 Million ≈ $-3.27 Million	-44.224x	-5189.34%
2009-12-31	Skr30.21 Million ≈ $3.25 Million	Skr-25.26 Million ≈ $-2.72 Million	-0.836x	+63.51%
2008-12-31	Skr15.23 Million ≈ $1.64 Million	Skr-34.89 Million ≈ $-3.75 Million	-2.291x	--

About Moberg Pharma AB (publ)

ST:MOB Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$49.06 Million

Skr455.91 Million SEK

Market Cap Rank

#21908 Global

#410 in Sweden

Share Price

Skr9.70

Change (1 day)

+2.65%

52-Week Range

Skr7.79 - Skr12.40

All Time High

Skr226.13